Zoetis Inc. $ZTS Shares Sold by Legacy Wealth Management LLC MS

Legacy Wealth Management LLC MS lessened its stake in Zoetis Inc. (NYSE:ZTS) by 39.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 8,705 shares of the company’s stock after selling 5,719 shares during the quarter. Legacy Wealth Management LLC MS’s holdings in Zoetis were worth $1,095,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. North Star Asset Management Inc. raised its position in shares of Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock worth $225,000 after buying an additional 67 shares in the last quarter. Bank of Nova Scotia Trust Co. boosted its holdings in shares of Zoetis by 4.6% in the second quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock valued at $264,000 after acquiring an additional 74 shares in the last quarter. Summit Place Financial Advisors LLC increased its stake in shares of Zoetis by 0.4% during the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock valued at $2,834,000 after acquiring an additional 76 shares during the period. First County Bank CT increased its stake in shares of Zoetis by 5.4% during the third quarter. First County Bank CT now owns 1,535 shares of the company’s stock valued at $225,000 after acquiring an additional 79 shares during the period. Finally, CWA Asset Management Group LLC raised its holdings in Zoetis by 1.1% during the third quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after purchasing an additional 80 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ZTS shares. HSBC set a $140.00 price target on Zoetis in a research note on Wednesday, December 10th. Leerink Partners reissued a “market perform” rating on shares of Zoetis in a research note on Tuesday, March 10th. BTIG Research restated a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a report on Thursday, February 26th. Piper Sandler reaffirmed a “neutral” rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Finally, The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a research report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $152.91.

Zoetis Stock Performance

Zoetis stock opened at $116.03 on Friday. Zoetis Inc. has a fifty-two week low of $114.47 and a fifty-two week high of $172.23. The firm’s 50 day simple moving average is $124.58 and its 200-day simple moving average is $130.88. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. The company has a market cap of $48.98 billion, a P/E ratio of 19.27, a price-to-earnings-growth ratio of 1.79 and a beta of 0.95.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 12th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The firm had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. During the same quarter last year, the business posted $1.40 EPS. The company’s revenue was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.